Overview

Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B Patients

Status:
Completed
Trial end date:
2021-06-22
Target enrollment:
Participant gender:
Summary
This study was designed to evaluate the rate of subjects with HBV DNA less than 20 IU/mL after taking TenofoBell® tablet for 48 weeks
Phase:
Phase 4
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical